AB
Anixa Biosciences Inc
🇩🇪XFRA.CY71GermanyHealthcare
€2.40EURup +0.05 (+2.13%)After-hoursEnd of day8:11 PM
Price€2.40+0.05 (+2.13%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US03528H1095
- CUSIP
- Not reported
Company
- Employees
- 4
- Headquarters
- San Jose, United States
- Website
- https://www.anixa.com
- CEO
- Dr. Amit Kumar Ph.D.
Market
- Shares outstanding
- 32.9M
- Market cap
- €79M
Key dates
- Next earnings
- Jan 12, 2027
Highlights
No high and low reported for today's session.
- Market cap
- €79M
- EPS LTM
- -$0.31
- P/E LTM
- -11.06
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$10.42M+6.23%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$7.38M-7.76%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.